日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
World
Home / World / Americas

Pfizer strikes global licensing deal for COVID pill

Updated: 2021-11-17 06:19
Share
Share - WeChat
Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Freiburg, Germany, in this undated handout photo obtained by Reuters on November 16, 2021. [Photo/Agencies]

GENEVA - US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world's least-wealthy countries.

Pfizer will sub-licence production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent of the world's population.

Under the deal struck with the global Medicines Patent Pool (MPP), Pfizer -- which also produces one of the most widely-used Covid vaccines with German lab BioNTech -- will not receive royalties from the generic manufacturers, making the treatment cheaper.

The agreement is subject to the oral antiviral medication passing ongoing trials and regulatory approval.

The Pfizer drug is to be taken with the HIV medicine ritonavir.

Interim data from ongoing trials demonstrated an 89 percent reduction in the risk of Covid-19-related hospitalisation or death compared to a placebo, in non-hospitalised high-risk adults with Covid-19 within three days of symptom onset, said Pfizer.

Similar results were seen within five days of symptom onset, it added.

The Geneva-based MPP is a United Nations-backed international organisation that works to facilitate the development of medicines for low- and middle-income nations.

If approved, the pill could be on the market in "a matter of months", MPP policy chief Esteban Burrone told AFP.

Pfizer also said Tuesday that it was seeking an emergency use authorisation, or EUA, in the US for the Covid pill.

AFP

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 草草影院永久地址 | 激情视频一区 | aaa毛片免费观看 | 色噜噜狠狠大色综合 | 日韩精品一区二区三区在线观看 | 免费观看www | 日韩精品av一区二区三区 | 狠狠干夜夜草 | 成人性爱视频在线观看 | 亚洲电影一区二区 | 黄视频网站免费观看 | 夜夜操天天操 | 亚洲色图片区 | 五月天婷婷网亚洲综合在线 | 午夜男人女人爽爽爽视频 | 天海翼视频在线 | 成人网在线观看 | 午夜小网站 | 精产国产伦理一二三区 | 精品欧美乱码久久久久久 | caoliushequ2017| 91看片入口 | 欧美精品九九99久久在观看 | www.aiqingdao | 国产欧美精品午夜在线播放 | 国产精品国产三级国产a | 成年人免费网 | 日韩一级欧美一级毛片在线 | 国内精品99 | 一区二区三区在线播放 | 毛片在线视频 | 精品72久久久久久久中文字幕 | 亚洲视频在线观看一区 | 国产视频在 | 欧美一级aⅴ毛片 | 亚洲婷婷综合中文字幕第一页 | 午夜精品久久久久久99热7777 | 伊人久久综合 | 99这里只有精品6 | 国产成人啪精品视频免费网站软件 | 成人欧美s视频在线观看 |